With innovation in technology, artificial intelligence, defense, and life sciences driving investor demand, Israeli companies are poised to capitalize on a strengthening US IPO market in 2026.
Israeli companies have a long and successful track record in the US capital markets. Since the 1980s, hundreds of Israeli companies have listed on the Nasdaq or NYSE, and approximately 100 are currently listed—more than from any other foreign country apart from China and Canada. This leadership reflects Israel’s position as a global hub for innovation. US-listed Israeli companies span diverse industries, with fast-growing technology and life sciences companies particularly well-represented. Following a strong recovery of the initial public offering (IPO) markets, and significant M&A and foreign investment in the Israeli technology sector in 2025, the stage is set for continued momentum in 2026.
The US capital markets offer unparalleled opportunities for Israeli technology and life sciences companies to raise the capital necessary to achieve growth and global scale. A listing on a US exchange provides access to the world’s deepest pools of institutional and retail capital, attracting investment from both US and international investors. An NYSE or Nasdaq listing delivers liquidity, visibility, and credibility—often catalyzing strategic partnerships, M&A opportunities, and enhanced brand recognition. As the IPO market strengthens and investor appetite for innovation-driven companies intensifies, the window of opportunity for Israeli issuers is widening.
Click here to view the full article